PATENT CLAIM ANALYSIS

Application Number: 16005488
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "230500"]

Abstract:
The present invention provides compounds represented by formula (I), pharmaceutically acceptable salts thereof, N-oxides thereof, solvates thereof or prodrugs thereof (wherein the characters are as defined in the description). The compounds represented by formula (I) have affinity and selectivity for the gamma-aminobutyric acid A receptor subunit alpha 5 (GABA A  α5) and act as GABA A  α5 negative allosteric modulators (GABA A  α5 NAM), so that they are useful in the prevention and/or treatment of diseases which are related to the GABA A  α5 such as Alzheimer's disease.

Claim (Index 11):
The compound according to  claim 7 , wherein monocyclic 1  represents 6-membered mono-cyclic aromatic ring having 0 to 2 nitrogen atom and Cyc 2  represents nitrogen-containing 5- to 6-membered mono-cyclic aromatic heterocyclic ring having 1 to 3 heteroatoms independently selected from nitrogen, oxygen and sulfur, which may be substituted with 1 to 3 groups selected from halogen, cyano, hydroxy and C1-4 alkyl which may be substituted with 1 to 3 groups selected from halogen and hydroxy.

Metadata:
- Claim Count in Document: 27.0
- Percentile: 94.0
- Lexical Diversity: 1.64062
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15112647', '14208067', '14376307', '10149852', '11942480']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.812197810923804
- 35 USC 102 Novelty (BERT): 0.5978612661980305
- Combined Prediction Score: 0.7907641564512268
- Mean Citation Score: 380.78577
- Max Citation Score: 515.1568
- Similarity Product: 475.4715987148285

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test